Designation of front line hospitals and recognizing uncompensated costs in hospital specific DSH limit; funding for social determinants of health and physical and mental health comorbidities; 340B Drug Discount Program; funding for community project; funding for serving migrant patients; H.R.7327 - Protecting Front Line Multimission Hospitals Act of 2024.
Designation of front line hospitals and recognizing uncompensated costs in hospital specific DSH limit; community project funding; funding for social determinants of health and physical and mental health comorbidities, S.3450 - Mental and Physical Health Care Comorbidities Act of 2023.
Duration: January 1, 2018
to
present
General Issues: Health Issues , Medicare/Medicaid
Spending: about $1,000,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2018: U.S. Senate, House of Representatives, Health & Human Services - Dept of (HHS)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, HOLLAND & KNIGHT LLP lobbied for Denver Health and Hospital Authority , earning $40,000. The report was filed on April 22.
Original Filing: 301576572.xml
Lobbying Issues
Designation of front line hospitals and recognizing uncompensated costs in hospital specific DSH limit; funding for social determinants of health and physical and mental health comorbidities; 340B Drug Discount Program; funding for community project; funding for serving migrant patients; H.R.7327 - Protecting Front Line Multimission Hospitals Act of 2024.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Designation of front line hospitals and recognizing uncompensated costs in hospital specific DSH limit; community project funding; funding for social determinants of health and physical and mental health comorbidities, S.3450 - Mental and Physical Health Care Comorbidities Act of 2023.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2023
In Q4, HOLLAND & KNIGHT LLP lobbied for Denver Health and Hospital Authority , earning $40,000. The report was filed on Jan. 22.
Original Filing: 301540760.xml
Lobbying Issues
Designation of front line hospitals and recognizing uncompensated costs in hospital specific DSH limit; funding for social determinants of health and physical and mental health comorbidities; 340B Drug Discount Program; Pandemic & All-Hazards Preparedness Reauthorization, including statutory codification of certain disaster preparedness and response programs at the Administration for Strategic Preparedness & Response.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Designation of front line hospitals and recognizing uncompensated costs in hospital specific DSH limit; community project funding; funding for social determinants of health and physical and mental health comorbidities.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2023
In Q3, HOLLAND & KNIGHT LLP lobbied for Denver Health and Hospital Authority , earning $40,000. The report was filed on Oct. 19, 2023.
Original Filing: 301506954.xml
Lobbying Issues
Designation of front line hospitals and recognizing uncompensated costs in hospital specific DSH limit; funding for social determinants of health and physical and mental health comorbidities; 340B Drug Discount Program; Pandemic & All-Hazards Preparedness Reauthorization, including statutory codification of certain disaster preparedness and response programs at the Administration for Strategic Preparedness & Response.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Designation of front line hospitals and recognizing uncompensated costs in hospital specific DSH limit; community project funding; funding for social determinants of health and physical and mental health comorbidities.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2023
In Q2, HOLLAND & KNIGHT LLP lobbied for Denver Health and Hospital Authority , earning $40,000. The report was filed on July 19, 2023.
Original Filing: 301484219.xml
Lobbying Issues
Designation of front line hospitals and recognizing uncompensated costs in hospital specific DSH limit; funding for social determinants of health and physical and mental health comorbidities; 340B Drug Discount Program; Pandemic & All-Hazards Preparedness Reauthorization, including statutory codification of certain disaster preparedness and response programs at the Administration for Strategic Preparedness & Response.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Designation of front line hospitals and recognizing uncompensated costs in hospital specific DSH limit; community project funding; funding for social determinants of health and physical and mental health comorbidities.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2023
In Q1, HOLLAND & KNIGHT LLP lobbied for Denver Health and Hospital Authority , earning $40,000. The report was filed on April 19, 2023.
Original Filing: 301455947.xml
Lobbying Issues
Designation of front line hospitals and recognizing uncompensated costs in hospital specific DSH limit; community project funding; funding for social determinants of health and physical and mental health comorbidities; 340B Drug Discount Program.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Designation of front line hospitals and recognizing uncompensated costs in hospital specific DSH limit; community project funding; funding for social determinants of health and physical and mental health comorbidities.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2022
In Q4, HOLLAND & KNIGHT LLP lobbied for Denver Health and Hospital Authority , earning $40,000. The report was filed on Jan. 19, 2023.
Original Filing: 301432278.xml
Lobbying Issues
Designation of front line hospitals and recognizing uncompensated costs in hospital specific DSH limit; community project funding; funding for social determinants of health and physical and mental health comorbidities.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Designation of front line hospitals and recognizing uncompensated costs in hospital specific DSH limit; community project funding; funding for social determinants of health and physical and mental health comorbidities.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2022
In Q3, HOLLAND & KNIGHT LLP lobbied for Denver Health and Hospital Authority , earning $40,000. The report was filed on Oct. 19, 2022.
Original Filing: 301411879.xml
Lobbying Issues
Designation of front line hospitals and recognizing uncompensated costs in hospital specific DSH limit; community project funding; funding for social determinants of health and physical and mental health comorbidities.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Designation of front line hospitals and recognizing uncompensated costs in hospital specific DSH limit; community project funding; funding for social determinants of health and physical and mental health comorbidities.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2022
In Q2, HOLLAND & KNIGHT LLP lobbied for Denver Health and Hospital Authority , earning $40,000. The report was filed on July 16, 2022.
Original Filing: 301381757.xml
Lobbying Issues
Designation of front line hospitals and recognizing uncompensated costs in hospital specific DSH limit; community project funding; funding for social determinants of health and physical and mental health comorbidities.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Designation of front line hospitals and recognizing uncompensated costs in hospital specific DSH limit; community project funding; funding for social determinants of health and physical and mental health comorbidities.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2022
In Q1, HOLLAND & KNIGHT LLP lobbied for Denver Health and Hospital Authority , earning $40,000. The report was filed on April 19, 2022.
Original Filing: 301363893.xml
Lobbying Issues
Designation of front line hospitals and recognizing uncompensated costs in hospital specific DSH limit; community project funding for substance abuse and behavioral health; funding for social determinants of health and modernizing the safety-net; pursue inclusion of front line hospitals in Hill Burton reauthorization as part of Build Better Act; funding of graduate medical education in Build Back Better Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Designation of front line hospitals and recognizing uncompensated costs in hospital specific DSH limit; community project funding for substance abuse and behavioral health; funding for social determinants of health and modernizing the safety-net.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2021
In Q4, HOLLAND & KNIGHT LLP lobbied for Denver Health and Hospital Authority , earning $40,000. The report was filed on Jan. 19, 2022.
Original Filing: 301329814.xml
Lobbying Issues
Designation of front line hospitals and recognizing uncompensated costs in hospital specific DSH limit; community project funding for substance abuse and behavioral health; funding for social determinants of health and modernizing the safety-net; pursue inclusion of front line hospitals in Hill Burton reauthorization as part of Build Better Act; funding of graduate medical education in Build Back Better Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Designation of front line hospitals and recognizing uncompensated costs in hospital specific DSH limit; community project funding for substance abuse and behavioral health; funding for social determinants of health and modernizing the safety-net.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2021
In Q3, HOLLAND & KNIGHT LLP lobbied for Denver Health and Hospital Authority , earning $40,000. The report was filed on Oct. 19, 2021.
Original Filing: 301306502.xml
Lobbying Issues
Designation of front line hospitals and recognizing uncompensated costs in hospital specific DSH limit; community project funding for substance abuse and behavioral health; funding for social determinants of health and modernizing the safety-net; pursue inclusion of front line hospitals in Hill Burton reauthorization as part of Build Better Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Designation of front line hospitals and recognizing uncompensated costs in hospital specific DSH limit; community project funding for substance abuse and behavioral health; funding for social determinants of health and modernizing the safety-net.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2021
In Q2, HOLLAND & KNIGHT LLP lobbied for Denver Health and Hospital Authority , earning $40,000. The report was filed on July 20, 2021.
Original Filing: 301284312.xml
Lobbying Issues
Designation of front line hospitals and recognizing uncompensated costs in hospital specific DSH limit; community project funding for substance abuse and behavioral health; funding for social determinants of health and modernizing the safety-net.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Designation of front line hospitals and recognizing uncompensated costs in hospital specific DSH limit; community project funding for substance abuse and behavioral health; funding for social determinants of health and modernizing the safety-net.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2021
In Q1, HOLLAND & KNIGHT LLP lobbied for Denver Health and Hospital Authority , earning $40,000. The report was filed on April 17, 2021.
Original Filing: 301255067.xml
Lobbying Issues
Designation of front line hospitals and recognizing uncompensated costs in hospital specific DSH limit; community project funding for substance abuse and behavioral health.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Designation of front line hospitals and recognizing uncompensated costs in hospital specific DSH limit; community project funding for substance abuse and behavioral health.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2020
In Q4, HOLLAND & KNIGHT LLP lobbied for Denver Health and Hospital Authority , earning $40,000. The report was filed on Jan. 20, 2021.
Original Filing: 301240334.xml
Lobbying Issues
CARES Provider relief funding and prioritization of super safety-net hospitals; funding for community health centers.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Designation of front line hospitals and inclusion of physician, clinic and ambulance costs in the disproportionate share hospital specific limit.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2020
In Q3, HOLLAND & KNIGHT LLP lobbied for Denver Health and Hospital Authority , earning $40,000. The report was filed on Oct. 19, 2020.
Original Filing: 301214704.xml
Lobbying Issues
340B Drug Pricing Program; Disproportionate Share Hospital (DSH) Payments; Medicaid reform; Medicare delivery; Community Health Center Funding; designation of front line hospitals in federal law; demonstration program for Medicare & Medicaid; funding for Ebola centers; issues related to CARES Act provider relief funding for air ambulance providers due to COVID-19 pandemic.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
340B Drug Pricing Program; Disproportionate Share Hospital (DSH) Payments; Medicaid reform; Medicare delivery; Community Health Center Funding; Children's Health Insurance Program (CHIP); demonstration program for front-line hospitals; demonstration program for Medicare and Medicaid.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2020
In Q2, HOLLAND & KNIGHT LLP lobbied for Denver Health and Hospital Authority , earning $40,000. The report was filed on July 20, 2020.
Original Filing: 301199721.xml
Lobbying Issues
340B Drug Pricing Program; Disproportionate Share Hospital (DSH) Payments; Medicaid reform; Medicare delivery; Community Health Center Funding; funding for opioid addiction; designation of front line hospitals in federal law; demonstration program for Medicare & Medicaid; funding for Ebola centers; issues related to CARES Act provider relief funding for air ambulance providers due to COVID-19 pandemic.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
340B Drug Pricing Program; Disproportionate Share Hospital (DSH) Payments; Medicaid reform; Medicare delivery; Community Health Center Funding; Children's Health Insurance Program (CHIP); demonstration program for front-line hospitals; demonstration program for Medicare and Medicaid.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2020
In Q1, HOLLAND & KNIGHT LLP lobbied for Denver Health and Hospital Authority , earning $40,000. The report was filed on April 13, 2020.
Original Filing: 301165908.xml
Lobbying Issues
340B Drug Pricing Program; Disproportionate Share Hospital (DSH) Payments; Medicaid reform; Medicare delivery; Community Health Center Funding; funding for opioid addiction; designation of front line hospitals in federal law; demonstration program for Medicare & Medicaid; funding for Ebola centers.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
340B Drug Pricing Program; Disproportionate Share Hospital (DSH) Payments; Medicaid reform; Medicare delivery; Community Health Center Funding; Children's Health Insurance Program (CHIP); demonstration program for front-line hospitals; demonstration program for Medicare and Medicaid.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2019
In Q4, HOLLAND & KNIGHT LLP lobbied for Denver Health and Hospital Authority , earning $40,000. The report was filed on Jan. 11, 2020.
Original Filing: 301104473.xml
Lobbying Issues
340B Drug Pricing Program; Disproportionate Share Hospital (DSH) Payments; Medicaid reform; Medicare delivery; Community Health Center Funding; funding for opioid addiction; designation of front line hospitals in federal law; demonstration program for Medicare & Medicaid; funding for Ebola centers.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
340B Drug Pricing Program; Disproportionate Share Hospital (DSH) Payments; Medicaid reform; Medicare delivery; Community Health Center Funding; Children's Health Insurance Program (CHIP); demonstration program for front-line hospitals; demonstration program for Medicare and Medicaid.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2019
In Q3, HOLLAND & KNIGHT LLP lobbied for Denver Health and Hospital Authority , earning $40,000. The report was filed on Oct. 21, 2019.
Original Filing: 301074419.xml
Lobbying Issues
340B Drug Pricing Program; Disproportionate Share Hospital (DSH) Payments; Medicaid reform; Medicare delivery; Community Health Center Funding; funding for opioid addiction; designation of front line hospitals in federal law; demonstration program for Medicare & Medicaid; funding for Ebola centers.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
340B Drug Pricing Program; Disproportionate Share Hospital (DSH) Payments; Medicaid reform; Medicare delivery; Community Health Center Funding; Children's Health Insurance Program (CHIP); demonstration program for front-line hospitals; demonstration program for Medicare and Medicaid.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2019
In Q2, HOLLAND & KNIGHT LLP lobbied for Denver Health and Hospital Authority , earning $40,000. The report was filed on July 19, 2019.
Original Filing: 301051488.xml
Lobbying Issues
340B Drug Pricing Program; Disproportionate Share Hospital (DSH) Payments; Affordable Care Act repeal efforts; Medicaid reform; Medicare delivery; Community Health Center Funding; Children's Health Insurance Program (CHIP); Pandemic and All-Hazards Act reauthorization; funding for opioid addiction; designation of front line hospitals in federal law; demonstration program for Medicare & Medicaid.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
340B Drug Pricing Program; Disproportionate Share Hospital (DSH) Payments; Medicaid reform; Medicare delivery; Community Health Center Funding; Children's Health Insurance Program (CHIP); demonstration program for front-line hospitals; demonstration program for Medicare and Medicaid.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2019
In Q1, HOLLAND & KNIGHT LLP lobbied for Denver Health and Hospital Authority , earning $40,000. The report was filed on April 22, 2019.
Original Filing: 301034621.xml
Lobbying Issues
340B Drug Pricing Program; Disproportionate Share Hospital (DSH) Payments; Affordable Care Act repeal efforts; Medicaid reform; Medicare delivery; Community Health Center Funding; Children's Health Insurance Program (CHIP); Pandemic and All-Hazards Act reauthorization; funding for opioid addiction.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
340B Drug Pricing Program; Disproportionate Share Hospital (DSH) Payments; Medicaid reform; Medicare delivery; Community Health Center Funding; Children's Health Insurance Program (CHIP); demonstration program for front-line hospitals.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2018
In Q4, HOLLAND & KNIGHT LLP lobbied for Denver Health and Hospital Authority , earning $40,000. The report was filed on Jan. 22, 2019.
Original Filing: 301017423.xml
Lobbying Issues
340B Drug Pricing Program; Disproportionate Share Hospital (DSH) Payments; Affordable Care Act repeal efforts; Medicaid reform; Medicare delivery; Community Health Center Funding; Children's Health Insurance Program (CHIP); Pandemic and All-Hazards Act reauthorization; funding for opioid addiction.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
340B Drug Pricing Program; Disproportionate Share Hospital (DSH) Payments; Affordable Care Act repeal efforts; Medicaid reform; Medicare delivery; Community Health Center Funding; Children's Health Insurance Program (CHIP).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2018
In Q3, HOLLAND & KNIGHT LLP lobbied for Denver Health and Hospital Authority , earning $40,000. The report was filed on Oct. 19, 2018.
Original Filing: 300990402.xml
Lobbying Issues
340B Drug Pricing Program; Disproportionate Share Hospital (DSH) Payments; Affordable Care Act repeal efforts; Medicaid reform; Medicare delivery; Community Health Center Funding; Children's Health Insurance Program (CHIP); Pandemic and All-Hazards Act reauthorization; funding for opioid addiction.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
340B Drug Pricing Program; Disproportionate Share Hospital (DSH) Payments; Affordable Care Act repeal efforts; Medicaid reform; Medicare delivery; Community Health Center Funding; Children's Health Insurance Program (CHIP).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2018
In Q2, HOLLAND & KNIGHT LLP lobbied for Denver Health and Hospital Authority , earning $40,000. The report was filed on July 6, 2018.
Original Filing: 300962649.xml
Lobbying Issues
340B Drug Pricing Program; Disproportionate Share Hospital (DSH) Payments; Affordable Care Act repeal efforts; Medicaid reform; Medicare delivery; Community Health Center Funding; Children's Health Insurance Program (CHIP); Pandemic and All-Hazards Act reauthorization; funding for opioid addiction.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
340B Drug Pricing Program; Disproportionate Share Hospital (DSH) Payments; Affordable Care Act repeal efforts; Medicaid reform; Medicare delivery; Community Health Center Funding; Children's Health Insurance Program (CHIP).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2018
In Q1, HOLLAND & KNIGHT LLP lobbied for Denver Health and Hospital Authority , earning $40,000. The report was filed on April 20, 2018.
Original Filing: 300953862.xml
Lobbying Issues
340B Drug Pricing Program; Disproportionate Share Hospital (DSH) Payments; Affordable Care Act repeal efforts; Medicaid reform; Medicare delivery; Community Health Center Funding; Children's Health Insurance Program (CHIP); Pandemic and All-Hazards Act reauthorization; funding for opioid addiction.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
340B Drug Pricing Program; Disproportionate Share Hospital (DSH) Payments; Affordable Care Act repeal efforts; Medicaid reform; Medicare delivery; Community Health Center Funding; Children's Health Insurance Program (CHIP).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2018
HOLLAND & KNIGHT LLP filed a lobbying registration on Feb. 13, 2018 to represent Denver Health and Hospital Authority, effective Jan. 1, 2018.
Original Filing: 300940209.xml
Issue(s) they said they’d lobby about: 340B Drug Pricing Program; Disproportionate Share Hospital (DSH) Payments; Affordable Care Act repeal efforts; Medicaid reform; Medicare delivery; Community Health Center Funding; Children's Health Insurance Program (CHIP). .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate